Back to CHRS Stock Lookup
Pages: 1 2 »» Last Page

Coherus BioSciences (CHRS) – Company Press Releases

Sep 27, 2016 08:00 AM Coherus BioSciences Regains Development and Commercial Rights to CHS-0214 From Shire
Sep 16, 2016 07:00 PM Coherus BioSciences Announces New Employment Inducement Grants
Sep 1, 2016 02:00 PM Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in September 
Aug 31, 2016 05:17 PM Coherus BioSciences Announces New Employment Inducement Grants
Aug 9, 2016 04:01 PM Coherus BioSciences Reports Second Quarter 2016 Financial and Operating Results
Aug 9, 2016 01:54 PM Coherus BioSciences Submits 351(k) Biologics License Application to U.S. Food and Drug Administration for CHS-1701 (Pegfilgrastim Biosimilar Candidate)
Aug 8, 2016 08:38 AM Coherus BioSciences Announces Positive Topline Phase Three Results for CHS-1420 (Humira® Biosimilar Candidate) in Patients with Psoriasis
Jul 25, 2016 11:00 AM Coherus BioSciences to Report Second Quarter 2016 Financial Results on August 9th
Jul 11, 2016 08:30 AM Coherus Announces Positive Topline Results for CHS-1701 (Pegfilgrastim Biosimilar Candidate) Pharmacokinetic and Pharmacodynamic Biosimilarity Study
Jun 28, 2016 09:00 AM HealthCare Royalty Partners Commits $205 Million to New Investments Over the First Half of 2016
Jun 28, 2016 09:00 AM Coherus Announces Positive Phase 2b Efficacy Data on Novel Oral Therapy in Relapsing Remitting Multiple Sclerosis
Jun 13, 2016 02:04 PM Coherus BioSciences Provides Update on IPRs
Jun 10, 2016 12:05 PM Coherus Presents Study Results Demonstrating Equivalence of its CHS-0214 Biosimilar to Etanercept
Jun 3, 2016 09:00 AM Coherus BioSciences to Present at Jefferies 2016 Healthcare Conference on June 8
May 26, 2016 02:51 PM Coherus BioSciences Advances Differentiated IP Strategy for Humira Market Access
May 23, 2016 09:20 AM Coherus Prices Public Offering of Common Stock
May 23, 2016 06:09 AM Coherus Announces Proposed Public Offering of Common Stock
May 17, 2016 10:31 AM Coherus BioSciences Provides Update on ‘135 IPR
May 16, 2016 04:01 PM Coherus BioSciences Appoints Patrick O’Brien as Senior Vice President, Investor Relations
May 9, 2016 04:01 PM Coherus BioSciences Reports First Quarter 2016 Financial and Operating Results
May 4, 2016 09:30 AM Coherus BioSciences to Present at Bank of America Merrill Lynch Health Care Conference on May 11
May 2, 2016 09:30 AM Coherus BioSciences to Report First Quarter 2016 Financial Results on May 9
Mar 29, 2016 09:30 AM Coherus BioSciences to Present at Barclays Generic Pharmaceuticals Symposium on April 6
Mar 7, 2016 09:30 AM Coherus BioSciences to Present at Barclays Global Healthcare Conference on March 16
Feb 29, 2016 04:01 PM Coherus BioSciences Reports Fourth Quarter and Year End 2015 Financial and Operating Results
Feb 29, 2016 09:30 AM Coherus BioSciences Announces Private Placement of $100 Million Senior Convertible Notes
Feb 26, 2016 09:30 AM Coherus BioSciences to Present at Cowen and Company Healthcare Conference on March 8
Feb 15, 2016 09:30 AM Coherus BioSciences to Report Fourth Quarter and Year End 2015 Financial Results on February 29
Feb 5, 2016 09:30 AM Coherus BioSciences to Present at Bloomberg Intelligence Healthcare Event on February 12th
Feb 1, 2016 04:15 PM Coherus Announces the Appointment of Jim Daly, Executive Chairman, Commercial Advisory Committee
Feb 1, 2016 04:05 PM Coherus Announces CHS-1701 (Neulasta® Biosimilar) Met Both Primary Endpoints in Registration-Enabling Immunogenicity Study
Jan 11, 2016 06:45 AM Coherus and Baxalta Announce CHS-0214 (Investigational Etanercept Biosimilar) Met Primary Efficacy Endpoint in Phase 3 Rheumatoid Arthritis Clinical Study (RaPsODY)
Jan 4, 2016 09:30 AM Coherus BioSciences to Present at J.P. Morgan Healthcare Conference on January 11
Dec 21, 2015 09:30 AM Coherus BioSciences Signs Strategic Manufacturing Agreement With KBI Biopharma for Commercial Supply of CHS-1701
Dec 8, 2015 04:00 PM Coherus BioSciences Reports Update to CHS-1701 Program
Nov 10, 2015 09:30 AM Coherus BioSciences to Present at Jefferies Autumn 2015 Global Healthcare Conference on November 18
Nov 9, 2015 04:05 PM Coherus BioSciences Reports Third Quarter 2015 Financial and Operating Results and Corporate Events
Nov 9, 2015 04:01 PM Coherus and Baxalta Announce CHS-0214 (Investigational Etanercept Biosimilar) Met Primary Efficacy Endpoints in Phase 3 Psoriasis Clinical Study (RaPsODY)
Oct 28, 2015 09:30 AM Coherus BioSciences to Present at Credit Suisse Healthcare Conference on November 10
Oct 27, 2015 09:30 AM Coherus BioSciences to Present at Bloomberg Biosimilars Conference on November 2
Oct 26, 2015 04:30 PM Coherus BioSciences to Report Third Quarter 2015 Financial Results on November 9
Oct 1, 2015 04:08 PM Coherus Announces Topline Results of CHS-1701 Pharmacokinetic and Pharmacodynamic Biosimilarity Study
Oct 1, 2015 04:08 PM Coherus Announces Topline Results of CHS-1701 Pharmacokinetic and Pharmacodynamic Biosimilarity Study
Sep 9, 2015 09:00 AM Coherus Appoints Juliana M. Reed, Vice President, Government Affairs
Sep 4, 2015 09:00 AM Coherus BioSciences to Present at Morgan Stanley Global Healthcare Conference on September 17
Sep 4, 2015 09:00 AM Coherus BioSciences to Present at Morgan Stanley Global Healthcare Conference on September 17
Sep 3, 2015 04:01 PM Coherus Provides Updates on Clinical Studies
Sep 3, 2015 04:01 PM Coherus Provides Updates on Clinical Studies
Aug 10, 2015 04:02 PM Coherus BioSciences Reports Second Quarter 2015 Financial and Operating Results
Aug 10, 2015 04:02 PM Coherus BioSciences Reports Second Quarter 2015 Financial and Operating Results
Pages: 1 2 »» Last Page

Back to CHRS Stock Lookup